Infectious Disease Molecular Diagnostics Market Size, Share & Trends Report

Infectious Disease Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Technology (Mass Spectrometry, PCR, In Situ Hybridization), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report ID: GVR-4-68039-529-7
  • Number of Report Pages: 100
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2024
  • Forecast Period: 2025 - 2030 
  • Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                    1.3. Research Methodology
                        1.3.1. Information Procurement
                        1.3.2. Information or Data Analysis
                        1.3.3. Market Formulation & Data Visualization
                        1.3.4. Data Validation & Publishing
                    1.4. Research Scope and Assumptions
                        1.4.1. List of Data Sources
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. Infectious Disease Molecular Diagnostics Market Variables, Trends, & Scope
                    3.1. Market Introduction/Lineage Outlook
                    3.2. Market Size and Growth Prospects (USD Million)
                    3.3. Market Dynamics
                        3.3.1. Market Drivers Analysis
                        3.3.2. Market Restraints Analysis
                    3.4. Infectious Disease Molecular Diagnostics Market Analysis Tools
                        3.4.1. Porter’s Analysis
                            3.4.1.1. Bargaining power of the suppliers
                            3.4.1.2. Bargaining power of the buyers
                            3.4.1.3. Threats of substitution
                            3.4.1.4. Threats from new entrants
                            3.4.1.5. Competitive rivalry
                        3.4.2. PESTEL Analysis
                            3.4.2.1. Political landscape
                            3.4.2.2. Economic and Social landscape
                            3.4.2.3. Technological landscape
                            3.4.2.4. Environmental landscape
                            3.4.2.5. Legal landscape
Chapter 4. Infectious Disease Molecular Diagnostics Market: Product Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Infectious Disease Molecular Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million)
                    4.3. Instruments
                        4.3.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.4. Reagents
                        4.4.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.5. Services
                        4.5.1. Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Infectious Disease Molecular Diagnostics Market: Technology Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Infectious Disease Molecular Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Million)
                    5.3. Polymerase Chain Reaction (PCR)
                        5.3.1. Polymerase Chain Reaction (PCR) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.3.2. Multiplex PCR
                            5.3.2.1. Multiplex PCR Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.2. Instruments
                                5.3.2.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.3. Reagents
                                5.3.2.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.4. Others
                                5.3.2.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.3.3. Other PCR
                                5.3.3.1.1. Other PCR Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.4. In Situ Hybridization
                        5.4.1. In Situ Hybridization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.2. Instruments
                            5.4.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.3. Reagents
                            5.4.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.4. Others
                            5.4.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.5. Isothermal Nucleic Acid Amplification Technology (INAAT)
                        5.5.1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.5.2. Instruments
                            5.5.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.5.3. Reagents
                            5.5.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.5.4. Others
                            5.5.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.6. Chips and Microarrays
                        5.6.1. Chips and Microarrays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.6.2. Instruments
                            5.6.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.6.3. Reagents
                            5.6.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.6.4. Others
                            5.6.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.7. Mass Spectrometry
                        5.7.1. Mass Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.7.2. Instruments
                            5.7.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.7.3. Reagents
                            5.7.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.7.4. Others
                            5.7.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.8. Sequencing
                        5.8.1. Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.8.2. Instruments
                            5.8.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.8.3. Reagents
                            5.8.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.8.4. Others
                            5.8.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.9. Transcription Mediated Amplification
                        5.9.1. Transcription Mediated Amplification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.9.2. Instruments
                            5.9.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.9.3. Reagents
                            5.9.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.9.4. Others
                            5.9.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.10. Others
                        5.10.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.10.2. Instruments
                            5.10.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.10.3. Reagents
                            5.10.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.10.4. Others
                            5.10.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Infectious Disease Molecular Diagnostics Market: Application Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Infectious Disease Molecular Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Million)
                    6.3. Respiratory Diseases
                        6.3.1. Respiratory Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.4. Tuberculosis
                        6.4.1. Tuberculosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.5. Meningitis
                        6.5.1. Meningitis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.6. Gastrointestinal Tract Infections
                        6.6.1. Gastrointestinal Tract Infections Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.7. HPV
                        6.7.1. HPV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.8. Sexually Transmitted Infections
                        6.8.1. Sexually Transmitted Infections Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.9. Sepsis
                        6.9.1. Sepsis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.10. Drug Resistance Diseases
                        6.10.1. Drug Resistance Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.11. Others
                        6.11.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Infectious Disease Molecular Diagnostics Market: End Use Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. Infectious Disease Molecular Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
                    7.3. Hospitals
                        7.3.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.4. Clinics
                        7.4.1. Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.5. Diagnostics Laboratories
                        7.5.1. Diagnostics Laboratories Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.6. Research Institutes
                        7.6.1. Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Infectious Disease Molecular Diagnostics Market: Regional Estimates & Trend Analysis
                    8.1. Infectious Disease Molecular Diagnostics Market Share, By Region, 2024 & 2030 (USD Million)
                    8.2. North America
                        8.2.1. North America Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.2.2. U.S.
                            8.2.2.1. U.S. Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.2.3. Canada
                            8.2.3.1. Canada Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.2.4. Mexico
                            8.2.4.1. Mexico Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.3. Europe
                        8.3.1. Europe Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.3.2. UK
                            8.3.2.1. UK Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.3.3. Germany
                            8.3.3.1. Germany Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.3.4. France
                            8.3.4.1. France Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.3.5. Italy
                            8.3.5.1. Italy Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.3.6. Spain
                            8.3.6.1. Spain Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.3.7. Denmark
                            8.3.7.1. Denmark Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.3.8. Sweden
                            8.3.8.1. Sweden Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.3.9. Norway
                            8.3.9.1. Norway Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.4. Asia Pacific
                        8.4.1. Asia Pacific Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.4.2. Japan
                            8.4.2.1. Japan Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.4.3. China
                            8.4.3.1. China Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.4.4. India
                            8.4.4.1. India Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.4.5. Australia
                            8.4.5.1. Australia Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.4.6. South Korea
                            8.4.6.1. South Korea Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.4.7. Thailand
                            8.4.7.1. Thailand Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.5. Latin America
                        8.5.1. Latin America Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.5.2. Brazil
                            8.5.2.1. Brazil Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.5.3. Argentina
                            8.5.3.1. Argentina Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.6. Middle East and Africa
                        8.6.1. Middle East and Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.6.2. South Africa
                            8.6.2.1. South Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.6.3. Saudi Arabia
                            8.6.3.1. South Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.6.4. UAE
                            8.6.4.1. UAE Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        8.6.5. Kuwait
                            8.6.5.1. Kuwait Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
                    9.1. Recent Developments & Impact Analysis by Key Market Participants
                    9.2. Company Categorization
                    9.3. Company Heat Map Analysis
                    9.4. Company Profiles
                        9.4.1. Abbott
                            9.4.1.1. Participant’s Overview
                            9.4.1.2. Financial Performance
                            9.4.1.3. Product Benchmarking
                            9.4.1.4. Recent Developments/ Strategic Initiatives
                        9.4.2. Danaher Corporation
                            9.4.2.1. Participant’s Overview
                            9.4.2.2. Financial Performance
                            9.4.2.3. Product Benchmarking
                            9.4.2.4. Recent Developments/ Strategic Initiatives
                        9.4.3. bioMérieux SA
                            9.4.3.1. Participant’s Overview
                            9.4.3.2. Financial Performance
                            9.4.3.3. Product Benchmarking
                            9.4.3.4. Recent Developments/ Strategic Initiatives
                        9.4.4. F. Hoffmann-La Roche Ltd
                            9.4.4.1. Participant’s Overview
                            9.4.4.2. Financial Performance
                            9.4.4.3. Product Benchmarking
                            9.4.4.4. Recent Developments/ Strategic Initiatives
                        9.4.5. Bio-Rad Laboratories, Inc.
                            9.4.5.1. Participant’s Overview
                            9.4.5.2. Financial Performance
                            9.4.5.3. Product Benchmarking
                            9.4.5.4. Recent Developments/ Strategic Initiatives
                        9.4.6. Agilent Technologies, Inc.
                            9.4.6.1. Participant’s Overview
                            9.4.6.2. Financial Performance
                            9.4.6.3. Product Benchmarking
                            9.4.6.4. Recent Developments/ Strategic Initiatives
                        9.4.7. Becton, Dickinson and Company
                            9.4.7.1. Participant’s Overview
                            9.4.7.2. Financial Performance
                            9.4.7.3. Product Benchmarking
                            9.4.7.4. Recent Developments/ Strategic Initiatives
                        9.4.8. Hologic, Inc. (Gen-Probe)
                            9.4.8.1. Participant’s Overview
                            9.4.8.2. Financial Performance
                            9.4.8.3. Product Benchmarking
                            9.4.8.4. Recent Developments/ Strategic Initiatives
                        9.4.9. Grifols S.A.
                            9.4.9.1. Participant’s Overview
                            9.4.9.2. Financial Performance
                            9.4.9.3. Product Benchmarking
                            9.4.9.4. Recent Developments/ Strategic Initiatives
                        9.4.10. Qiagen
                            9.4.10.1. Participant’s Overview
                            9.4.10.2. Financial Performance
                            9.4.10.3. Product Benchmarking
                            9.4.10.4. Recent Developments/ Strategic Initiatives
                        9.4.11. Siemens Healthineers AG
                            9.4.11.1. Participant’s Overview
                            9.4.11.2. Financial Performance
                            9.4.11.3. Product Benchmarking
                            9.4.11.4. Recent Developments/ Strategic Initiatives
                        9.4.12. Sysmex Corporation
                            9.4.12.1. Participant’s Overview
                            9.4.12.2. Financial Performance
                            9.4.12.3. Product Benchmarking
                            9.4.12.4. Recent Developments/ Strategic Initiatives


List of Tables

Table 1 List of abbreviation
Table 2 Global infectious disease molecular diagnostics market, by region, 2018 - 2030 (USD Million)
Table 3 Global infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 4 Global infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 5 Global infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 6 Global infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 7 North America infectious disease molecular diagnostics market, by country, 2018 - 2030 (USD Million)
Table 8 North America infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 9 North America infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 10 North America infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 11 North America infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 12 U.S. infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 13 U.S. infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 14 U.S. infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 15 U.S. infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 16 Canada infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 17 Canada infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 18 Canada infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 19 Canada infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 20 Mexico infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 21 Mexico infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 22 Mexico infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 23 Mexico infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 24 Europe infectious disease molecular diagnostics market, by country, 2018 - 2030 (USD Million)
Table 25 Europe infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 26 Europe infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 27 Europe infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 28 Europe infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 29 UK infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 30 UK infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 31 UK infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 32 UK infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 33 Germany infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 34 Germany infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 35 Germany infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 36 Germany infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 37 France infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 38 France infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 39 France infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 40 France infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 41 Italy infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 42 Italy infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 43 Italy infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 44 Italy infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 45 Spain infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 46 Spain infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 47 Spain infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 48 Spain infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 49 Denmark infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 50 Denmark infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 51 Denmark infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 52 Denmark infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 53 Sweden infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 54 Sweden infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 55 Sweden infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 56 Sweden infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 57 Norway infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 58 Norway infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 59 Norway infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 60 Norway infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 61 Asia Pacific infectious disease molecular diagnostics market, by country, 2018 - 2030 (USD Million)
Table 62 Asia Pacific infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 63 Asia Pacific infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 64 Asia Pacific infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 65 Asia Pacific infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 66 Japan infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 67 Japan infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 68 Japan infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 69 Japan infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 70 China infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 71 China infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 72 China infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 73 China infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 74 India infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 75 India infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 76 India infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 77 India infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 78 Australia infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 79 Australia infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 80 Australia infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 81 Australia infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 82 South Korea infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 83 South Korea infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 84 South Korea infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 85 South Korea infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 86 Thailand infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 87 Thailand infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 88 Thailand infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 89 Thailand infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 90 Latin America infectious disease molecular diagnostics market, by country, 2018 - 2030 (USD Million)
Table 91 Latin America infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 92 Latin America infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 93 Latin America infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 94 Latin America infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 95 Brazil infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 96 Brazil infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 97 Brazil infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 98 Brazil infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 99 Argentina infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 100 Argentina infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 101 Argentina infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 102 Argentina infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 103 MEA infectious disease molecular diagnostics market, by country, 2018 - 2030 (USD Million)
Table 104 MEA infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 105 MEA infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 106 MEA infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 107 MEA infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 108 South Africa infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 109 South Africa infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 110 South Africa infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 111 South Africa infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 116 UAE infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 117 UAE infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 118 UAE infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 119 UAE infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 120 Kuwait infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 121 Kuwait infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 122 Kuwait infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 123 Kuwait infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Infectious disease molecular diagnostics market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 Infectious disease molecular diagnostics market: Product outlook key takeaways
Fig. 20 Infectious disease molecular diagnostics market: Product movement analysis
Fig. 21 Transfemoral market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Infectious disease molecular diagnostics market: Technology outlook key takeaways
Fig. 26 Infectious disease molecular diagnostics market: Technology movement analysis
Fig. 27 Polymerase Chain Reaction (PCR) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 In Situ Hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Isothermal Nucleic Acid Amplification Technology (INAAT) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Chips and Microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Mass Spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Transcription Mediated Amplification market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Multiplex PCR market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Other PCR market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Infectious disease molecular diagnostics market: Application outlook key takeaways
Fig. 58 Infectious disease molecular diagnostics market: Application movement analysis
Fig. 59 Respiratory Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Tuberculosis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Meningitis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Gastrointestinal Tract Infections market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 HPV market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Sexually Transmitted Infections market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Sepsis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Drug Resistance Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Infectious disease molecular diagnostics market: End use outlook key takeaways
Fig. 69 Infectious disease molecular diagnostics market: End use movement analysis
Fig. 70 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Diagnostics Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Research Institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Regional marketplace outlook, 2024 & 2030 (USD Million)
Fig. 75 Regional marketplace: Key takeaways
Fig. 76 North America infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 U.S. infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Canada infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Mexico infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Europe infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 UK infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 Germany infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 France infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 Spain infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Italy infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 Denmark infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 Sweden infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Norway infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Asia Pacific infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Key country dynamics
Fig. 102 Japan infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 103 Key country dynamics
Fig. 104 China infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Key country dynamics
Fig. 106 India infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 Australia infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 109 Key country dynamics
Fig. 110 South Korea infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 111 Key country dynamics
Fig. 112 Thailand infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 113 Key country dynamics
Fig. 114 Market participant categorization
Fig. 115 Infectious disease molecular diagnostics market position analysis, 2023
Fig. 116 Strategic framework

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon